Page last updated: 2024-10-28

gyki 52466 and Stroke

gyki 52466 has been researched along with Stroke in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gressens, P1
Spedding, M1
Gigler, G1
Kertesz, S1
Villa, P1
Medja, F1
Williamson, T1
Kapus, G1
Levay, G1
Szenasi, G1
Barkoczy, J1
Harsing, LG1

Other Studies

1 other study available for gyki 52466 and Stroke

ArticleYear
The effects of AMPA receptor antagonists in models of stroke and neurodegeneration.
    European journal of pharmacology, 2005, Sep-05, Volume: 519, Issue:1-2

    Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Brain; Brain Ischemia; Cell Survival; C

2005